← 返回

基于深度学习的 TILScout 对 28 种癌症中 TIL(肿瘤浸润淋巴细胞)的预测与分析

英文原题:Prediction and analysis of tumor infiltrating lymphocytes across 28 cancers by TILScout using deep learning.

查看英文原题

Prediction and analysis of tumor infiltrating lymphocytes across 28 cancers by TILScout using deep learning.

PubMed 2025/03/19(内容时间) NPJ Precis Oncol Q1 · IF 9.9(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

TIL(肿瘤浸润淋巴细胞)的密度是预测抗肿瘤应答的重要指标,但其在不同癌种中的广泛影响仍未得到充分研究。研究者提出 TILScout,这是一种泛癌深度学习方法,可从全切片图像(WSI)计算图像块级别的 TIL 评分。在验证集和独立测试集中,TILScout 将 WSI 图像块分类为 TIL 阳性、TIL 阴性及其他/坏死三类的准确率分别为 0.9787 和 0.9628,AUC 分别为 0.9988 和 0.9934,优于既往研究。研究者通过全面的功能和相关性分析,验证了 TILScout 评分在 28 种癌症中的生物学意义。癌症分期越高,TIL 评分越低,这一一致趋势直接支持 TIL 含量较低可能促进癌症进展。此外,TIL 评分与免疫检查点基因表达以及常见癌症驱动基因的基因组变异相关。这项全面的泛癌调查凸显了 TIL 在肿瘤微环境中的重要预后意义。

展开英文摘要原文

The density of tumor-infiltrating lymphocytes (TILs) serves as a valuable indicator for predicting anti-tumor responses, but its broad impact across various types of cancers remains underexplored.

We introduce TILScout, a pan-cancer deep-learning approach to compute patch-level TIL scores from whole slide images (WSIs). TILScout achieved accuracies of 0. 9787 and 0. 9628, and AUCs of 0. 9988 and 0. 9934 in classifying WSI patches into three categories-TIL-positive, TIL-negative, and other/necrotic-on validation and independent test sets, respectively, surpassing previous studies.

The biological significance of TILScout-derived TIL scores across 28 cancers was validated through comprehensive functional and correlational analyses. A consistent decrease in TIL scores with an increase in cancer stage provides direct evidence that the lower TIL content may stimulate cancer progression.

Additionally, TIL scores correlated with immune checkpoint gene expression and genomic variation in common cancer driver genes.

Our comprehensive pan-cancer survey highlights the critical prognostic significance of TILs within the tumor microenvironment.

论文信息

作者
Zhang H、Chen L、Li L、Liu Y、Das B、Zhai S、Tan J、Jiang Y
第一作者单位
Department of Bioinformatics, TUM School of Life Sciences, Technical University of Munich, Freising, Germany.Germany
通讯作者单位
Department of Bioinformatics, TUM School of Life Sciences, Technical University of Munich, Freising, Germany. dimitri.frischmann@tum.de.Germany
期刊
NPJ precision oncology2025 Mar 19
原文标识
PubMed 40108446 · DOI 10.1038/s41698-025-00866-0